FBXW7 and acute lymphoblastic leukemia: Activating mutations found in ATL patients are different from those previously reported in patients with T-ALL and mostly involve single-substitution mutations in the PEST domain that do not create an early stop codon, but rather lead to reduced CDC4/Fbw7-mediated degradation and stabilization of NICD1 [17].